A bipartisan bill allocating support for hepatitis infection prevention and treatment has been introduced into the U.S. House of Representatives.

New Delhi, Nov 21 : About 20,000 patients in India could be at risk of getting infected blood -- unknown to them and even the donors.

SUMMARY: The European AIDS Clinical Society released updated HIV treatment guidelines last week at the group's annual conference in Cologne.

Main Category: Liver Disease / Hepatitis Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 18 Nov 2009 - 3:00 PST InterMune, Inc.

A new genetically engineered treatment for hemophilia, a dreaded disease where blood doesn't clot, was launched here Wednesday by a private pharmaceutical company.

Scientists at a group of 11 research centers in China are reporting for the first time assembly of the largest-ever collection of data about the proteins produced by genes in a single human organ.

Delegates of Saskatchewana TMs third annual Aboriginal HIV-AIDS and Hepatitis C conference marched through downtown Regina for missing First Nations women on Sunday.

There are ancient songs First Nations women used to sing in the forest to heal their injured men, songs of anguish and of strength, set to the heartbeat rhythm of a healing drum.

MORE than 270 people will need to be tested for blood borne diseases after a failure in sterilisation procedures at a southern Queensland hospital.

The latest issue of the Journal of Viral Hepatitis investigates Virological and clinical characteristics of delta hepatitis in Central Europe.

Hepatitis C virus infection is a risk factor for gallstone disease, finds the most recent issue of the Journal of Viral Hepatitis.

The massive assortment of lawsuits over last year's hepatitis outbreak could be taking another detour.

Novelos Therapeutics, Inc. , a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos issued and sold to Purdue Pharma L.P., an existing investor, 8,333,334 shares of Novelosa common stock and warrants, expiring on December 31, 2015, to purchase 2,916,668 shares of common ...

Aduro BioTech, a privately held biotechnology company focused on the development of therapeutic and prophylactic vaccines based on proprietary recombinant strains of the bacterium Listeria monocytogenes, today announced completion of its Series A-1 financing.

Biopharmaceutical firm Dynavax Technologies Corp. /quotes/comstock/15*!dvax /quotes/nls/dvax on Tuesday said it had exercised its option to purchase all of the equity of Symphony Dynamo Inc.

A new study by Mount Sinai researchers has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat.

The most recent issue of Hepatology Research investigates a new scoring system for predicting relapse after lamivudine-induced hepatitis B e-antigen loss in chronic hepatitis B patients.

Browse> Home / Briefs , Daily Dose / Daily Dose & Announcements: 11/03/09 Daily Dose & Announcements: 11/03/09 >>Naturalization Event for South Asians in Montgomery County >>First Specific Viral Hepatitis & Liver Cancer Prevention Bill Introduced >>Free Hep B Vaccination and Screening >>Japanese-American Musician Emiko Featured at Japan Music Week ...

Long-term Studies Show Tenofovir Safety and Efficacy Is Sustained at 3 Years in HBeAg Positive and Negative Hepatitis B Patients SUMMARY: Long-term follow-up data from 2 clinical trials show that tenofovir remained active against hepatitis B virus and was generally well-tolerated for up to 3 years, researchers reported this past weekend at the 60th ...

It has several forms, the most common of which are A and type B. It may also produce other types, include hepatitis C, D, E and G. The disease can produce mild disease or, at times, can be fulminant, and lead to death.